Letter
S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals
L.A. Cerezo1, B. Šumová2, H. Hulejová3, H. Štorkánová4, L. Szczuková5, M. Tomčík6, R. Bečvář7, K. Pavelka8, J. Vencovský9, J. Závada10, L. Šenolt11
- Institute of Rheumatology, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. senolt@revma.cz
CER11371
2019 Vol.37, N°2
PI 0338, PF 0339
Letter
Free to view
(click on article PDF icon to read the article)
PMID: 30719969 [PubMed]
Received: 02/05/2018
Accepted : 31/08/2018
In Press: 04/02/2019
Published: 19/03/2019